Paul Higham

Company: Valo Therapeutics Ltd.

Seminars:

PeptiVAX, a Vaccine Platform for Flexibly Targeting New & Emerging Infectious Disease 4:00 pm

PeptiVAX is a platform based on peptide antigen coating of nonreplicating adenovirus for delivery of peptide vaccination in infectious diseases. Costly and time-consuming genetic engineering of new vaccines to emerging infectious diseases is not required A pancoronavirus vaccine strategy targeting existing and emerging strains of coronavirus utilizing novel antigens will be describedRead more

day: Day Two